Firms May Offer Drug Info To Patients In Europe, But To Satisfy Consumer Rights
This article was originally published in The Pink Sheet Daily
Executive Summary
Patient rights to access information on prescription drugs could mean that industry should be permitted to provide data, says a draft EU report.
You may also be interested in...
EU Pharma Reorg Leaves Questions About How R&D Will Be Supported
Responsibility for setting pharmaceutical policy across the European Union shifted in late November from the European Commission's Enterprise & Industry department to its Health department
EU Tackles Counterfeits, But Parallel Trade Poses Tough Issues
Tackling counterfeit drugs is one pillar of the European Commission's package of new proposed pharmaceutical legislation. It will mean higher costs for most drug firms, while significant loopholes will remain
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.